Skip to main content

Focusing on the brain, cognition and behavior

Scientific rigor and reporting standards

The Editors of Molecular Autism would like to draw the attention of all authors to our latest guidance on the journal’s expectations regarding scientific rigor and reporting standards. Suitably large sample sizes, small P values including correction for multiple testing, confirmatory replication studies, estimates of effect size, and a Limitations section will be required for submissions to Molecular Autism. All submissions to the journal will be reviewed in accordance with these requirements. Click to read more about the journals submission requirements.

Read More

10 Years of Molecular Autism

New Content Item2020 marked a decade since Molecular Autism was established to accelerate and integrate research into neurodevelopmental conditions.

Read our retrospective collection of the most impactful publications from the last ten years here

Announcing the launch of In Review

In partnership with Research SquareMolecular Autism is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

Read more about the full range of benefits of In Review and how to opt in, or see the In Review platform for yourself here.

Articles

Neuroimaging in Autism Spectrum Disorders

The aim of this Collection is to tackle challenges of understanding the neurobiology associated with neurodiversity, autism and broader neurodevelopmental conditions in the context of in-vivo neuroimaging of the brain in autistic individuals and broader neurodevelopmental conditions.

Read More

Collections

Microbiota-gut-brain jigsaw

The microbiota-gut-brain axis

Cross-journal collection

Editors-in-Chief

Catalina Betancur, MD, PhD, INSERM, CNRS, Sorbonne Université, France

Founding Editors

Simon Baron-Cohen, PhD, University of Cambridge, UK
Joseph Buxbaum, PhD, Icahn School of Medicine at Mount Sinai, New York, USA

Aims and scope

Molecular Autism is a peer-reviewed, open access journal that publishes high-quality basic, translational and clinical research that has relevance to the etiology, pathobiology, or treatment of autism and related neurodevelopmental conditions. Research that includes integration across levels is encouraged. Molecular Autism publishes empirical studies, reviews, and brief communications.

We encourage submissions from a range of fields including (but not restricted to) genetics, molecular neurobiology, neuropathology, neuroimaging, cognitive neuroscience, epidemiology, and biomarker discovery. Molecular Autism also publishes articles on screening, diagnosis and classification, including articles that consider subgrouping to refine our understanding of basic mechanisms. Intervention studies are also welcome, especially when considered with respect to revealing causal mechanisms.

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 6.2
    5-year Journal Impact Factor: 6.5
    Source Normalized Impact per Paper (SNIP): 1.687
    SCImago Journal Rank (SJR): 1.989

    Speed 2024
    Submission to first editorial decision (median days): 5
    Submission to acceptance (median days): 143

    Usage 2024
    Downloads: 1,280,695
    Altmetric mentions: 947